pSivida Corp (PSDV) CEO to Discuss Sustained Delivery of Antibodies in Ophthalmology and Systemic Disease at International Symposium on Integrated Functionalities
7/29/2013 7:26:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
pSivida Corp. (NASDAQ:PSDV), a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, has announced that pSivida President and Chief Executive Officer, Paul Ashton, Ph.D., will speak today at the International Symposium on Integrated Functionalities 2013 meeting at the Hilton DFW Lakes Executive Conference Center in Grapevine, Texas.
Help employers find you! Check out all the jobs and post your resume.
comments powered by